| Totaln (%) |
| Demographic characteristics |
| Age, years (± SD) |
71,9 ± 10,4 |
| Sex, men |
103 (93,6) |
| Former smokers |
30 (27,3) |
| Occupational history |
14 (15,7) |
| Influenzae / H1N1 vaccination |
65 (59,1) / 24 (21,8) |
| S. pneumoniaevaccination (last 10 years) |
51 (46,4) |
| AE-COPD in the last year |
51 (46,4) |
| COPD hospitalization in the last year |
45 (40,9) |
| Pneumonia in the last year |
9 (8,2) |
| Treatment |
| Oxygen long treatment |
33 (30) |
| Oral Corticoids |
19 (17,4) |
| Chronic antibiotics |
9 (8,2) |
| Comorbidities |
| Charslon index (± SD) |
2,38 ± 1,7 |
| Hypertension |
61 (55) |
| Dyslipidemia |
39 (35,5) |
| Diabetes mellitus |
32 (29,1) |
| Bronchiectasis |
31 (28,2) |
| Arrythmia |
23 (20,9) |
| Ischemic heart disease |
21 (19,1) |
| Apnea hypopnea syndrome |
18 (16,4) |
| Valvular heart disease |
16 (14,5) |
| Osteoporosis |
15 (13,6) |
| Tuberculosis |
13 (11,8) |
| Neoplasm |
12 (10,9) |
| Depression |
12 (10,9) |
| Heart failure |
9 (8,2) |
| Corpulmonale |
5 (4,5) |
| Obesity |
5 (4,5) |
| Functional status |
| Barthel scale (± DS) |
89 ± 19,7 |
| mMRC scale (± DS) |
1,86 ± 1 |
| COPD severity (GOLD) |
| Mild (>80) |
5 (4,7) |
| Moderate (50-80) |
36 (34) |
| Sever (30-50) |
32 (30,2) |
| Very sever (<30) |
33 (31,1) |
|
